Sponsorship verdict
Sponsorship possible
One solid signal, not two. Worth applying, and worth asking about sponsorship early.
-
✓
Employer is on a government sponsor recordThe US Department of Labor certified 3 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest May 2026) — the step every H-1B hire needs first.
-
?
The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
-
?
No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area.
-
✓
Confirmed live todayWhen a source last listed this job as open.
Details and sources
- Employer is on a government sponsor record
- The US Department of Labor certified 3 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest May 2026) — the step every H-1B hire needs first. Source: LCA disclosure data (US Department of Labor (OFLC)).
- No salary bar for this route
- H-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence. It is not legal advice and never a guarantee: the employer and the immigration authority decide. Sign in to factor in where you can already work.
About the role
Ocular Therapeutix, Inc. (NASDAQ:OCUL) is a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye using its proprietary bioresorbable hydrogel-based formulation technology, ELUTYX™. Ocular Therapeutix has built a robust product pipeline of drug delivery solutions developed to reduce the complexity and burden of the current standard of care and position itself to become a leader in the ophthalmic space.
Outside of the ophthalmic realm and behind the doors of our headquarters in Bedford, MA, we strive to build a strong culture where employees can flourish and achieve their career goals. We encourage out of the box thinking, cross-functional collaboration, and creativity.
• Position Summary :
• As the Corporate Account Director, you'll play a pivotal role in ensuring seamless access and fostering growth for our company's products specifically within the Retina Consultants of America (RCA) account. Your primary focus will be developing and executing account strategies while establishing and nurturing relationships with key stakeholders within the account's organization. You'll be instrumental in developing and implementing solutions and agreements that align with the company's growth initiatives while fostering strong, mutually beneficial partnerships.
• Target account: Retina Consultants of America (RCA)
• Principal Duties and Responsibilities include the following :
• National Account Strategy
• Develop and execute account strategy including contracting when appropriate, with overall responsibility for customer engagement across Retina Consultants of America
• Support launch planning for current and future products by developing product access strategies and tactics for Retina Consultants of America
• Identify competitive threats and develop response strategies to ensure continued and optimal access and product utilization across Retina Consultants of America
• Maintain business knowledge and understanding of RCA as well as the broader retina provider landscape to contribute to overall Market Access strategy across the portfolio
• National Account and Performance Management
• Develop strategic solutions and implement account plans for RCA, tied to measurable access, financial, and operational outcomes
• Establish accountability through QBRs, performance management, and data-driven insights
• Own account GTN performance across all OID, data, and service contracts, ensuring disciplined financial management and optimization
• Customer Relationships & Senior-Level Engagement
• Establish and maintain broad and deep touch points at senior leadership levels — including key decision-makers across C-suite, pharmacy leadership, trade relations and clinical management — to create and communicate the value of Ocular Therapeutix’s products
• Serve as the primary customer-facing lead for RCA, addressing access, pricing, contracting, and business needs
• Execute contract evaluation, GTN management, and negotiations across product portfolios
• Seek out opportunities for synergy and partnership through active and transparent customer planning to achieve both Ocular Therapeutix’s and account goals
• Cross-Functional Collaboration
• Effectively collaborate within Market Access and across Sales, Marketing, and Medical Affairs to develop strategic and tactical plans to ensure coordinated account pull-through across RCA
• Provide subject matter expertise to Commercial and Medical Affairs functions on specific RCA dynamics
• Leverage insights from customer interactions and cross-functional collaboration to refine go-to-market strategy, launch planning and child account pull through efforts
• Support field teams with tools, insights, an
Apply on company site ↗